Related Experiment Video
Updated: Jan 16, 2026

05:32
Author Spotlight: Characterizing DNA G-Quadruplex by Bis-3-Chloropiperidine Based Chemical Mapping
Published on: May 12, 2023
1.8K
Identification of Guanine-Quadruplex-Binding Peptides from the RGG3 Domain of TLS/FUS
Sayuri Takeo1, Maiko Tabata2, Hikari Okita3
1Graduate School of Medical Photonics, Shizuoka University, 3-5-1 Johoku, Chuo-ku, Hamamatsu 432-8011, Japan.
Chemical & Pharmaceutical Bulletin
|October 1, 2025
Summary
Researchers explored arginine-glycine-glycine (RGG)-rich peptides for binding guanine quadruplexes (G4s). Modified RGG peptides showed improved G4 RNA binding affinity and selectivity, offering potential for new G4-targeting therapeutics.
Area of Science:
- Biochemistry
- Molecular Biology
- Medicinal Chemistry
Background:
- Guanine quadruplexes (G4s) are non-canonical nucleic acid structures implicated in various biological processes.
- G4s are recognized as promising therapeutic targets.
- Peptides from G4-binding proteins offer selective G4 recognition platforms.
Purpose of the Study:
- To investigate the G4-binding capacity of arginine-glycine-glycine (RGG)-rich sequences derived from the RGG3 domain of TLS/FUS.
- To evaluate the G4-binding affinities of synthesized RGG peptides.
- To explore the impact of conformational constraints using (E)-methylalkene dipeptide isosteres (MADIs) on G4 recognition.
Main Methods:
- Synthesis of a peptide library of overlapping 15-mer RGG sequences.
- Evaluation of G4-binding affinities using binding assays.
- Generation and assessment of RGG peptidomimetics incorporating MADIs.
Main Results:
- Several native RGG peptides demonstrated measurable affinity for G4 RNA structures, with STK5-1 showing the highest affinity.
- RGG peptidomimetics with MADIs exhibited enhanced G4-binding affinity and selectivity compared to native peptides.
- Sequence and structural features governing G4-binding were elucidated.
Conclusions:
- RGG-rich peptides, particularly STK5-1, show potential for G4 RNA recognition.
- MADI modification can enhance the affinity and selectivity of RGG-based G4 ligands.
- These findings provide a basis for developing novel peptide-based G4 therapeutics.

